Year-Long epilepsy drug trial tests safety in devastating childhood conditions
NCT ID NCT05626634
Summary
This study tested the long-term safety of an experimental epilepsy drug called LP352 in people with severe, difficult-to-treat epilepsy syndromes like Dravet and Lennox-Gastaut. It followed 41 participants for up to 52 weeks to monitor side effects and see how well the drug continued to control seizures when added to their existing medications. The goal was to gather more information about the drug's safety profile and its ability to reduce seizures over a longer period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Advent Health Orlando
Orlando, Florida, 32803, United States
-
Alfred Health
Melbourne, Victoria, 3004, Australia
-
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
-
Austin Epilepsy Care Center
Austin, Texas, 78758, United States
-
Austin Health
Heidelberg, Victoria, 3084, Australia
-
Boston Children's Health Physicians LLP
Hawthorne, New York, 10532, United States
-
Child Neurology Consultants of Austin
Austin, Texas, 78757, United States
-
Hawaii Pacific Neuroscience
Honolulu, Hawaii, 96817, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland, 20817, United States
-
Northeast Regional Epilepsy Group
Staten Island, New York, 10305, United States
-
Northwell Health
New York, New York, 10075, United States
-
Northwest Florida Clinical Research Group
Gulf Breeze, Florida, 32561, United States
-
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
-
OnSite Clinical Solutions LLC
Charlotte, North Carolina, 98277, United States
-
Providence Neurological Specialties-East
Portland, Oregon, 97213, United States
-
Queensland Children's Hospital
South Brisbane, Queensland, 4101, Australia
-
Rancho Los Amigos National Rehabilitation Center (RLANRC)
Downey, California, 90242, United States
-
Research Institute of Orlando
Orlando, Florida, 32806, United States
-
Spectrum Health
Grand Rapids, Michigan, 49503, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of California San Francisco
San Francisco, California, 94158, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of South Florida
Tampa, Florida, 33606, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
-
University of Washington Valley Medical Center
Renton, Washington, 98055, United States
-
Wake Forest University School of Medicine
Winston-Salem, North Carolina, 27157, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.